🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Betsy Morrow

Center for Cancer Research

ORCID: 0000-0001-7112-1078
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression”.

Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.012
N/A
0.637DataRank · unranked
69 citations

Manakamana Khanal, Junko Murai, Jingli Zhang, Manjistha Sengupta, Qun Jiang +13 more

Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100231
N/A
0.609DataRank · unranked
57 citations

Idrees Mian, Cathy Wagner, Yvonne Mallory, Maria Agra, Betsy Morrow +7 more

Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2019652117
N/A
0.598DataRank · unranked
53 citations

Keisuke Goto, Güntülü Ak, Yoshie Yoshikawa, Mitsuru Emi, Sandra Pastorino +22 more

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models

Science Translational Medicine(2020)10.1126/scitranslmed.aaz7252
N/A
0.571DataRank · unranked
44 citations

Azam Ghafoor, Idrees Mian, Daniel Rathkey, Anish Thomas, Christine Alewine +8 more

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100938
N/A
0.500DataRank · unranked
27 citations

Qun Jiang, Jun S. Wei, Vikram Misra, Betsy Morrow, Chimene Kesserwan +11 more

Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9054
N/A
0.470DataRank · unranked
22 citations

Idrees Mian, Cathy Wagner, Yvonne Mallory, Maria Agra, Emerson Padiernos +8 more

Transcriptomics based prediction of survival and response to therapy in malignant mesothelioma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.13.488207
N/A
0DataRank · unranked
1 citations

Qun Jiang, Jun S. Wei, Vikram Misra, Betsy Morrow, Chimene Kesserwan +10 more